Citigroup’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4 | Hold |
|
|||||
|
2025
Q2 | $1 | Hold |
|
|||||
|
2025
Q1 | $1 | Sell |
|
|||||
|
2024
Q4 | $32.7K | Sell |
|
|||||
|
2024
Q3 | $204K | Hold |
|
|||||
|
2024
Q2 | $189K | Sell |
|
|||||
|
2024
Q1 | $576K | Buy |
|
|||||
|
2023
Q4 | $303K | Sell |
|
|||||
|
2023
Q3 | $299K | Sell |
|
|||||
|
2023
Q2 | $294K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $646 | Sell |
|
|||||
|
2022
Q3 | $155K | Sell |
|
|||||
|
2022
Q2 | $1.19M | Buy |
|
|||||
|
2022
Q1 | $942K | Buy |
|
|||||
|
2021
Q4 | $113K | Sell |
|
|||||
|
2021
Q3 | $207K | Buy |
|
|||||
|
2021
Q2 | $120K | Buy |
|
|||||
|
2021
Q1 | $62K | Sell |
|
|||||
|
2020
Q4 | $144K | Buy |
|
|||||
|
2020
Q3 | $98K | Sell |
|
|||||
|
2020
Q2 | $224K | Buy |
|
|||||
|
2020
Q1 | $58K | Buy |
|
|||||
|
2019
Q4 | $37K | Buy |
|